Olivia D. Lara

498 total citations
28 papers, 190 citations indexed

About

Olivia D. Lara is a scholar working on Oncology, Obstetrics and Gynecology and Molecular Biology. According to data from OpenAlex, Olivia D. Lara has authored 28 papers receiving a total of 190 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Obstetrics and Gynecology and 6 papers in Molecular Biology. Recurrent topics in Olivia D. Lara's work include COVID-19 and healthcare impacts (8 papers), Economic and Financial Impacts of Cancer (4 papers) and Cancer Genomics and Diagnostics (4 papers). Olivia D. Lara is often cited by papers focused on COVID-19 and healthcare impacts (8 papers), Economic and Financial Impacts of Cancer (4 papers) and Cancer Genomics and Diagnostics (4 papers). Olivia D. Lara collaborates with scholars based in United States, China and Türkiye. Olivia D. Lara's co-authors include Bhavana Pothuri, Anil K. Sood, Jason D. Wright, Justin Jee, Anne Knisely, Julia Fehniger, Roisin E. O’Cearbhaill, Megan E. Sutter, Wei Hu and Amma Asare and has published in prestigious journals such as Cancer, Scientific Reports and Obstetrics and Gynecology.

In The Last Decade

Olivia D. Lara

25 papers receiving 189 citations

Peers

Countries citing papers authored by Olivia D. Lara

Since Specialization

Citations

This map shows the geographic impact of Olivia D. Lara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivia D. Lara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivia D. Lara more than expected).

Fields of papers citing papers by Olivia D. Lara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivia D. Lara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivia D. Lara. The network helps show where Olivia D. Lara may publish in the future.

Co-authorship network of co-authors of Olivia D. Lara

This figure shows the co-authorship network connecting the top 25 collaborators of Olivia D. Lara. A scholar is included among the top collaborators of Olivia D. Lara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivia D. Lara. Olivia D. Lara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Associations between obesity and outcomes in pembrolizumab-treated endometrial cancer 2025 ·Gynecologic Oncology ·Briony Patterson, Nikita Sinha, (unknown), S. Craig Stocks, William C. Zamboni, Benjamin B. Albright, Paola A. Gehrig, Victoria Bae‐Jump, Olivia D. Lara	0
2	Race- associated molecular differences in uterine serous carcinoma 2024 ·Frontiers in Oncology ·Olivia D. Lara, Hannah Karpel, Steven Friedman, Kari Hacker, Bhavana Pothuri	1
3	Intermittent energy restriction inhibits tumor growth and enhances paclitaxel response in a transgenic mouse model of endometrial cancer 2024 ·Gynecologic Oncology ·Ziyi Zhao, Jiandong Wang, Weimin Kong, Ziwei Fang, Michael F. Coleman, Ginger L. Milne, (unknown), (unknown), Olivia D. Lara, Douglas S. Lee, Boer Deng, (unknown), (unknown), Wenchuan Sun, Stephen D. Hursting, Chunxiao Zhou, Victoria Bae‐Jump	1
4	SPL-108 mitigates metastasis and chemoresistance in tubo-ovarian carcinoma 2024 ·Translational Oncology ·Olivia D. Lara, (unknown), (unknown), Selim Mısırlıoğlu, Douglas A. Levine, Kari Hacker	1
5	Clinical trial screening in gynecologic oncology: Defining the need and identifying best practices 2024 ·Gynecologic Oncology ·(unknown), Olivia D. Lara, C Mccormick, (unknown), Victoria Bae‐Jump, Amanda Jackson, John F. Peppin, (unknown), Kathleen N. Moore, Bhavana Pothuri, (unknown), Tashanna Myers	2
6	Strategies to increase minority participation in clinical trial screening and enrollment in an urban academic public hospital (2237) 2023 ·Gynecologic Oncology ·Olivia D. Lara, (unknown), Michelle Lightfoot, Bhavana Pothuri	2
7	Race-associated Molecular Changes in Gynecologic Malignancies 2022 ·Cancer Research Communications ·Amma Asare, Hui Yao, Olivia D. Lara, Ying Wang, Lin Zhang, Anil K. Sood	7
8	Clinical outcomes in patients with COVID-19 and gynecologic cancer: A society of gynecologic oncology COVID-19 and gynecologic cancer registry study 2022 ·Gynecologic Oncology ·Gretchen Glaser, Olivia D. Lara, Bhavana Pothuri, (unknown), Lauren S. Prescott, Spyridon Mastroyannis, Sarah Kim, Adam C. ElNaggar, (unknown), Lesley B. Conrad, Michaela E. McGree, Amy L. Weaver, Warner K. Huh, David E. Cohn, Satoru Yamada, Amanda N. Fader	4
9	The association of tumor mutational burden, microsatellite stability, and mismatch repair deficiency in an endometrial cancer patient cohort (194) 2022 ·Gynecologic Oncology ·Sarah Lee, Olivia D. Lara, Hannah Karpel, Bhavana Pothuri	2
10	Impact of COVID-19 on gynecologic oncology patients: an SGO COVID-19 and Gynecologic Cancer Registry study (050) 2022 ·Gynecologic Oncology ·Gretchen Glaser, Olivia D. Lara, Bhavana Pothuri, (unknown), Lauren S. Prescott, Spyridon Mastroyannis, Sarah Kim, Adam C. ElNaggar, (unknown), Lesley B. Conrad, Michaela E. McGree, Amy L. Weaver, Warner K. Huh, David E. Cohn, Amanda N. Fader	1
11	RF3 The association of tumor mutational burden, microsatellite stability, and mismatch repair deficiency in an endometrial cancer patient cohort 2022 ·Gynecologic Oncology ·Sarah Lee, Olivia D. Lara, Hannah Karpel, Bhavana Pothuri	1
12	COVID-19 outcomes of patients with gynecologic cancer in New York City: An updated analysis from the initial surge of the pandemic 2021 ·Gynecologic Oncology ·Olivia D. Lara, (unknown), Yuyan Wang, Roisin E. O’Cearbhaill, Stephanie V. Blank, Valentin Kolev, Caitlin Carr, Anne Knisely, (unknown), (unknown), Eloise Chapman‐Davis, Seth A. Cohen, Julia Fehniger, Yi-Chun Lee, (unknown), Mengling Liu, Jason D. Wright, Bhavana Pothuri	8
13	COVID-19 outcomes of patients with gynecologic cancer in New York City: an updated analysis 2021 ·Gynecologic Oncology ·Olivia D. Lara, (unknown), Yuyan Wang, Roisin E. O’Cearbhaill, Stephanie V. Blank, Valentin Kolev, Caitlin Carr, Anne Knisely, (unknown), (unknown), Melissa K. Frey, Justin Jee, Julia Fehniger, Yi-Chun Lee, (unknown), Mengling Liu, Jason D. Wright, Bhavana Pothuri	1
14	Inflammatory markers in gynecologic oncology patients hospitalized with COVID-19 infection 2020 ·Gynecologic Oncology ·(unknown), Olivia D. Lara, Roisin E. O’Cearbhaill, Anne Knisely, (unknown), (unknown), Caitlin Carr, Stephanie V. Blank, Monica Prasad-Hayes, Melissa K. Frey, Justin Jee, Julia Fehniger, Yuyan Wang, Yi-Chun Lee, (unknown), Jason D. Wright, Bhavana Pothuri	9
15	Transient rise in CA 125 in a woman with ovarian carcinoma and COVID-19 infection 2020 ·Gynecologic Oncology Reports ·(unknown), Olivia D. Lara, Bhavana Pothuri	5
16	Tumor core biopsies adequately represent immune microenvironment of high-grade serous carcinoma 2019 ·Scientific Reports ·Olivia D. Lara, (unknown), Zhihui Wang, Sara Corvigno, (unknown), Yasmin Lyons, Robert Dood, Wei Hu, Lisha Qi, Jinsong Liu, Robert L. Coleman, Shannon N. Westin, Nicole D. Fleming, Vittorio Cristini, Arvind Rao, Jared K. Burks, Anil K. Sood	16
17	Pan‐cancer clinical and molecular analysis of racial disparities 2019 ·Cancer ·Olivia D. Lara, Ying Wang, Amma Asare, Tao Xu, Hua‐Sheng Chiu, Yuexin Liu, Wei Hu, Pavel Sumazin, Shitanshu Uppal, Lin Zhang, J. Alejandro Rauh‐Hain, Anil K. Sood	28
18	Grabbing the Grb2/GAB2 complex in ovarian cancer 2018 ·Gynecologic Oncology ·Olivia D. Lara, Cristian Rodriguez‐Aguayo, Emine Bayraktar, Paola Amero, (unknown), Christopher J. Lafargue, Anil K. Sood	2
19	ADH1B promotes mesothelial clearance and ovarian cancer infiltration 2018 ·Oncotarget ·Kshipra M. Gharpure, Olivia D. Lara, Yunfei Wen, Sunila Pradeep, Christopher J. Lafargue, Cristina Ivan, Rajesha Rupaimoole, Wei Hu, Lingegowda S. Mangala, Sherry Y. Wu, Archana S. Nagaraja, Keith Baggerly, Anil K. Sood	23
20	Diagnosis of Adenomyosis 2016 ·Obstetrics and Gynecology ·Olivia D. Lara, (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact